After skimming on low cap stocks which have huge growth potential but have been on signficant correction, I came across JAGX, a pharmaceutical company focused on developing plant-based, non-opioid, and sustainably derived prescription medicines.
Weekly data is showing weakening of sellers. An accumulation / net buying at the current price range has been spotted. Volume have increased from 1.73M to 2.22M.
Again, its a low cap -- and the catch with low cap stocks is liquidity. Be mindful on that aspect.
Spotted at 0.6090
TAYOR.